A Systematic Review and Meta-analysis on the Epidemiology of the Muscular Dystrophies
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Background:The muscular dystrophies are a heterogeneous group of genetic muscle diseases with variable distribution of weakness and mode of inheritance.Methods:We previously performed a systematic review of worldwide population-based studies on Duchenne and Becker muscular dystrophies; the current study focused on the epidemiology of other muscular dystrophies using Medline and EMBASE databases. Two reviewers independently reviewed all abstracts, full-text articles, and abstracted data from 1985 to 2011. Pooling of prevalence estimates was performed using random-effect models.Results:A total of 1104 abstracts and 167 full-text articles were reviewed. Thirty-one studies met all eligibility criteria and were included in the final analysis. The overall pooled prevalence of combined muscular dystrophies was 16.14 (confidence interval [CI], 11.21-23.23) per 100,000. The prevalence estimates per 100,000 were 8.26 (CI, 4.99-13.68) for myotonic dystrophy, 3.95 (CI, 2.89-5.40) for facioscapulohumeral dystrophy, 1.63 (CI, 0.94-2.81) for limb girdle muscular dystrophy, and 0.99 (CI, 0.62-1.57) for congenital muscular dystrophies.Conclusions:The studies differed widely in their approaches to case ascertainment, and substantial gaps remain in the global estimates of many other types of muscular dystrophies. Additional epidemiological studies using standardized diagnostic criteria as well as multiple sources of case ascertainment will help address the economic impact and health care burden of muscular dystrophies worldwide.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Conducting Meta-Analyses in R with the metafor Package
Viechtbauer, W. (2010) · Journal of Statistical Software · doi:10.18637/jss.v036.i03 · Cited by 20,464 · cited 1×
“The metafor package was used to produce the pooled estimates using restricted maximum likelihood estimation.(15)”
MethodBrook, J. D., McCurrach, M. E., Harley, H. G., Buckler, A. J., Church, D., Aburatani, H., Hunter, K., Stanton, V. P., Thirion, J.-P., Hudson, T., et al. (1992) · Cell · doi:10.1016/0092-8674(92)90154-5 · Cited by 2,777 · cited 1×
“3 for type 2 disease.(3,4) Myotonic dystrophy type 1 can be subdivided into several clinical phenotypes depending on the age of presentation, including congenital, early childhood, adult, and late-onset forms.”
BackgroundThe prevalence of Parkinson's disease: a systematic review and meta-analysis
Pringsheim, T., Jette, N., Frolkis, A., & Steeves, T. D. L. (2014) · Movement Disorders · doi:10.1002/mds.25945 · Cited by 2,188 · cited 2×
“Similarly, lower prevalence estimates were found in other systematic reviews of neurological conditions such as Huntington or Parkinson diseases in Asia.(41,42) However, Darin and Tulinius also restricted their sample population to those younger than 16 years of age and demonstrated a more typical prevalence estimate…”
ResultSelf-citationPopulation frequencies of inherited neuromuscular diseases—A world survey
Emery, A. E. H. (1991) · Neuromuscular Disorders · doi:10.1016/0960-8966(91)90039-u · Cited by 1,448 · cited 3×
“40) per 100,000, which is about twice as high as the estimate of 2 per 100,000 by Emery in 2001.(40) Study”
BackgroundInfluentialLemmers, R. J. L. F., Tawil, R., Petek, L. M., Balog, J., Block, G. J., Santen, G. W. E., Amell, A. M., van der Vliet, P. J., Almomani, R., Straasheijm, K. R., et al. (2012) · Nature Genetics · doi:10.1038/ng.2454 · Cited by 660 · cited 1×
“32 in association with a permission chromosome 4 allele account for the majority of type 2 disease.(6,7) It results in progressive atrophy and, frequently, asymmetrical weakness in a descending pattern.”
BackgroundThe incidence and prevalence of Huntington's disease: A systematic review and meta‐analysis
Pringsheim, T., Wiltshire, K., Day, L., Dykeman, J., Steeves, T., & Jette, N. (2012) · Movement Disorders · doi:10.1002/mds.25075 · Cited by 587 · cited 2×
“Similarly, lower prevalence estimates were found in other systematic reviews of neurological conditions such as Huntington or Parkinson diseases in Asia.(41,42) However, Darin and Tulinius also restricted their sample population to those younger than 16 years of age and demonstrated a more typical prevalence estimate…”
ResultSelf-citationNorwood, F. L. M., Harling, C., Chinnery, P. F., Eagle, M., Bushby, K., & Straub, V. (2009) · Brain · doi:10.1093/brain/awp236 · Cited by 541 · cited 6×
“On the other hand, advances in research activity may generate an increased awareness in a region for a particular group of disorders, as may be seen by Norwood et al within the United Kingdom.(26) Comparatively fewer cases of muscular dystrophy were diagnosed during the first 4 years of life, as indicated in a recent…”
BackgroundInfluentialA systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy
Mah, J. K., Korngut, L., Dykeman, J., Day, L., Pringsheim, T., & Jette, N. (2014) · Neuromuscular Disorders · doi:10.1016/j.nmd.2014.03.008 · Cited by 490 · cited 3×
“We previously reported on the epidemiology of Duchenne and Becker muscular dystrophies.(2) The purpose of this study is to systematically evaluate the worldwide incidence and prevalence of other muscular dystrophies including myotonic dystrophy, facioscapulohumeral dystrophy, limb girdle muscular dystrophy, and congen…”
BackgroundMethodSelf-citationMercuri, E., & Muntoni, F. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61897-2 · Cited by 434
Diagnostic approach to the congenital muscular dystrophies
Bönnemann, C. G., Wang, C. H., Quijano-Roy, S., Deconinck, N., Bertini, E., Ferreiro, A., Muntoni, F., Sewry, C., Béroud, C., Mathews, K. D., et al. (2014) · Neuromuscular Disorders · doi:10.1016/j.nmd.2013.12.011 · Cited by 340 · cited 1×
“It is further subdivided into disorders involving: (1) the basal lamina or extracellular matrix proteins; (2) alpha- dystroglycanopathy; (3) sarcoplasmic reticulum calcium release channel; (4) endoplasmic reticulum proteins; (5) nuclear envelope proteins; (5) mitochondrial membrane proteins; and (6) other unspecified…”
BackgroundGuidelines for evaluating prevalence studies
Boyle, M. H. (1998) · Evidence Based Mental Health · doi:10.1136/ebmh.1.2.37 · Cited by 313 · cited 1×
“Study Quality Two reviewers independently completed a quality review for each study using a modified existing quality assessment tool.(12) Quality scores were determined from eight key questions pertaining to sample representativeness, condition assessment, and THE CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES”
MethodGenetic mapping of a second myotonic dystrophy locus
Ranum, L. P. W., Rasmussen, P. F., Benzow, K. A., Koob, M. D., & Day, J. W. (1998) · Nature Genetics · doi:10.1038/570 · Cited by 264 · cited 2×
“3 for type 2 disease.(3,4) Myotonic dystrophy type 1 can be subdivided into several clinical phenotypes depending on the age of presentation, including congenital, early childhood, adult, and late-onset forms.”
BackgroundResultNarayanaswami, P., Weiss, M., Selcen, D., David, W., Raynor, E., Carter, G., Wicklund, M., Barohn, R. J., Ensrud, E., Griggs, R. C., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000892 · Cited by 232
Diagnostic criteria for facioscapulohumeral muscular dystrophy
Padberg, G. W., Lunt, P. W., Koch, M., & Fardeau, M. (1991) · Neuromuscular Disorders · doi:10.1016/0960-8966(91)90094-9 · Cited by 227 · cited 1×
“32 in association with a permission chromosome 4 allele account for the majority of type 2 disease.(6,7) It results in progressive atrophy and, frequently, asymmetrical weakness in a descending pattern.”
BackgroundRecommendations for optimal ICD codes to study neurologic conditions: A systematic review
St. Germaine-Smith, C., Metcalfe, A., Pringsheim, T., Roberts, J. I., Beck, C. A., Hemmelgarn, B. R., McChesney, J., Quan, H., & Jette, N. (2012) · Neurology · doi:10.1212/wnl.0b013e3182684707 · Cited by 206
Self-citationNeuromuscular disorders in childhood: a descriptive epidemiological study from western Sweden
Darin, N., & Tulinius, M. (2000) · Neuromuscular Disorders · doi:10.1016/s0960-8966(99)00055-3 · Cited by 205 · cited 2×
“Prevalence figures in school-aged children are therefore likely to give a better estimate of the true childhood prevalence of neuromuscular disorders.(16) As previously mentioned,(2) limitations of this systematic review include variability in methodology, nonrandom geographic distribution, and the lack of validated i…”
BackgroundMostacciuolo, M., Pastorello, E., Vazza, G., Miorin, M., Angelini, C., Tomelleri, G., Galluzzi, G., & Trevisan, C. (2009) · Clinical Genetics · doi:10.1111/j.1399-0004.2009.01158.x · Cited by 170
Cost of illness for neuromuscular diseases in the United States
Larkindale, J., Yang, W., Hogan, P. F., Simon, C. J., Zhang, Y., Jain, A., Habeeb‐Louks, E. M., Kennedy, A., & Cwik, V. A. (2014) · Muscle & Nerve · doi:10.1002/mus.23942 · Cited by 160 · cited 1×
“In the United States, the reported national costs of illness for Duchenne muscular dystrophy, myotonic dystrophy, and other progressive neuromuscular diseases has been estimated to exceed more than $1 billion per year.(46) Our pooled estimates are useful for calculating projections of expected case numbers in regions…”
BackgroundGenetic epidemiology of congenital muscular dystrophy in a sample from north-east Italy
Mostacciuolo, M. L., Miorin, M., Martinello, F., Angelini, C. I., Perini, P., & Trevisan, C. P. (1996) · Human Genetics · doi:10.1007/bf02185752 · Cited by 138
Flanigan, K. M., Coffeen, C. M., Sexton, L., Stauffer, D. M., Brunner, S., & Leppert, M. (2001) · Neuromuscular Disorders · doi:10.1016/s0960-8966(01)00201-2 · Cited by 133 · cited 2×
“Hughes et al,20 Magee and Nevin,21 Medica et al,22 Mladenovic et al,23 Mostacciuolo et al,24,25 Norwood et al,26 Siciliano et al,28 Sposito et al; Stensland et al,29 Urtasun et al,30 and van der Kooi et al.31 Three studies were from the Middle East, including Blumen et al,32 El-Tallawy et al,33 and Segel et al34; thre…”
BackgroundThe prevalence of inherited neuromuscular disease in Northern Ireland
Hughes, M. I., Hicks, E. M., Nevin, N. C., & Patterson, V. (1996) · Neuromuscular Disorders · doi:10.1016/0960-8966(94)00017-4 · Cited by 95
Epidemiology and inheritance of oculopharyngeal muscular dystrophy in Israel
Blumen, S. C., Nisipeanu, P., Sadeh, M., Asherov, A., Blumen, N., Wirguin, Y., Khilkevich, O., Carasso, R., & Korczyn, A. D. (1997) · Neuromuscular Disorders · doi:10.1016/s0960-8966(97)00080-1 · Cited by 65 · cited 2×
“Genetic data were not specified in earlier studies by Hughes et al,(20) Darin and Tulinius,(16) Chung et al,(35) El-Tallawy et al,(33) Mostacciuolo et al,(24) Nakagawa et al,(37) van der Kooi et al,(31) and Blumen et al.(32) Molecular genetic testing was used for diagnosis in some but not all patients in other studies…”
MethodPrevalence of Neuromuscular Diseases in Chinese Children: A Study in Southern China
Chung, B. H., Wong, V. C. N., & Ip, P. (2003) · Journal of Child Neurology · doi:10.1177/08830738030180030201 · Cited by 58 · cited 2×
“Variation in the reported prevalence of muscular dystrophies could be related to genetic variations between populations or ethnic groups as well as differences in available molecular diagnostic tools for accurate diagnosis.(35,36) Furthermore, neuromuscular disorders are relatively uncommon in the general population,…”
BackgroundEpidemiological and Genetic Studies of Myotonic Dystrophy Type 1 in Taiwan
Hsiao, K., Chen, S.-H., Li, S.-Y., Chiang, S.-M., Lin, H.-M., Pan, H., Huang, C., Kuo, H., Jou, S., Su, C. C., et al. (2003) · Neuroepidemiology · doi:10.1159/000071191 · Cited by 37 · cited 2×
“Variation in the reported prevalence of muscular dystrophies could be related to genetic variations between populations or ethnic groups as well as differences in available molecular diagnostic tools for accurate diagnosis.(35,36) Furthermore, neuromuscular disorders are relatively uncommon in the general population,…”
BackgroundCross-Canada Forum – National Population Health Study of Neurological Conditions in Canada
Caesar-Chavannes, C., & MacDonald, S. (2013) · Chronic diseases and injuries in Canada · doi:10.24095/hpcdp.33.3.09 · Cited by 30 · cited 1×
“This study was part of a larger initiative funded by the Public Health Agency of Canada to facilitate better understanding of the burden of neurological illnesses in Canada and worldwide.(11) METHODS Search Strategy The search strategy was developed by the study authors with expertise in neurology and epidemiology and…”
BackgroundMyotonic dystrophy in Otago, New Zealand.
Ford, C., Kidd, A., & Hammond-Tooke, G. D. (2006) · PubMed · Cited by 24
Sposìto, R., Pasquali, L., Galluzzi, F., Rocchi, A., Solito, B., Soragna, D., Tupler, R. G., & Siciliano, G. (2005) · Genetic Testing · doi:10.1089/gte.2005.9.30 · Cited by 19 · cited 2×
“Seven studies reported on all age groups, including El-Tallawy et al,(33) Flanigan et al,(39) Hughes et al,(20) Mostacciuolo et al,(25) Nakagawa et al,(37) Norwood et al,(26) and Sposito et al.(28) Two studies by Darin and Tulinius(16) and Chung et al(35) focused on children only (Figure 3).”
Background
Metadata
- Authors
- Mah, J. K., Korngut, L., Fiest, K. M., Dykeman, J., Day, L. J., Pringsheim, T., & Jette, N.
- Venue
- Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
- Publisher
- Cambridge University Press (CUP)
- Published
- 2015-11-24
- Volume
- 43
- Issue
- 1
- Pages
- 163-177
- ISSN
- 0317-1671 (ISSN-L)
- 2057-0155
- OpenAlex
- W2221483416
- Cited by
- 208
- References
- 27
- FWCI
- 0.60
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.